Sunday, November 8, 2026

USD/EUR Went Up By Over 1% In The Last 21 Sessions

USD/EUR Went Up By Over 1% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.53% for the last 21 sessions. At 10:06 EST on Tuesday, 25 June, USD/EUR (USDEUR) is $0.93.

USD/EUR's yearly highs and lows, it's 5.378% up from its 52-week low and 2.341% down from its 52-week high.

News about

  • Usd/cnh May follow usd/jpy if it breaks above 160 – societe generale. According to FXStreet on Tuesday, 25 June, "If USD/JPY does break through 160 in the coming days the USD/CNH pair may come along, Chief FX Strategist at Societe Generale Kit Juckes argues.", "If USD/JPY does break through 160 in the coming days, preventing further Yuan weakness would be very difficult indeed."
  • Usd/jpy price analysis: remains bullish amid intervention threats. According to FXStreet on Monday, 24 June, "The USD/JPY has managed to climb back above 159.00, even though traders were reluctant to re-test the Bank of Japan's (BoJ) patience of intervening in the FX space to tame the Japanese Yen (JPY) depreciation.", "If the USD/JPY clears the psychological 160.00 mark, the next resistance would be the year-to-date (YTD) high of 160.32. "
  • Usd/jpy: the pair flirts with 160 – societe generale. According to FXStreet on Monday, 24 June, "In early May 10-year Note yields were trading above 4.5% and USD/JPY was at 153, but here we are with yields down by 25bop and USD/JPY up near 160 again. "
  • According to FXStreet on Tuesday, 25 June, "The USD/JPY pair remains within touching distance of the 160.00 level that recently pushed Japanese authorities to spend billions of dollars in Yen-buying intervention, per Reuters.", "Surpassing the upper threshold of the ascending channel pattern around 159.90 will reinforce the bullish sentiment, potentially driving the USD/JPY pair toward 160.32, the highest level since April and a major resistance point."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com